49 reports

  • Risk Factors and Comorbidities for CKD
  • 4.1 BIBLIOGRAPHY

KIDNEY INTERNATIONAL SUPPLEMENTS; ##(##): ##-##.

  • Chronic Disease
  • Renal Disease
  • United Kingdom
  • United States
  • Forecast
  • Increasing Prevalence of Renal Diseases
  • Government Initiatives for Kidney Diseases

In chronic kidney disease the patient has either one or both damaged kidneys.

  • Renal Disease
  • North America
  • United States
  • World
  • Forecast
  • Stages of chronic kidney disease
  • Aranesp late-phase trial data in anemia in chronic kidney disease

American Journal of Kidney Diseases, ##(##), ##-## < DOI> ##. ##/ ##-##(##)##-##< / DOI>.

  • Renal Disease
  • Japan
  • United States
  • Amgen Inc.
  • Roche Group
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by Aronora Inc, H2 2019

The molecules developed by Companies in Phase II, Phase I, IND/ CTA Filed, Preclinical and Unknown stages are ##, ##, ##, ## and ## respectively.

  • Chronic Disease
  • Renal Disease
  • United States
  • World
  • Product Initiative
  • TOP COMPANIES PARTICIPATING IN END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS
  • TOP COMPANIES PARTICIPATING IN END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeutics, E## Countries, Clinical Trials by Phase, 2020* CLINICAL TRIALS BY PHASE IN E## COUNTRIES End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Therapeut

  • Chronic Disease
  • Clinical Trial
  • Hormone
  • Renal Disease
  • World
  • TOP COMPANIES PARTICIPATING IN POLYCYSTIC KIDNEY DISEASE THERAPEUTICS CLINICAL TRIALS
  • POLYCYSTIC KIDNEY DISEASE THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2020*

CLINICAL TRIALS BY PHASE IN G## COUNTRIES POLYCYSTIC KIDNEY DISEASE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2020* POLYCYSTIC KIDNEY DISEASE THERAPEUTICS, G## COUNTRIES, CLINICAL TRIALS BY PHASE, 2020* POLYCYSTIC KIDNEY DISEASE THERAPE

  • Pharmaceutical
  • Renal Disease
  • World
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.

Kidney Disease (Nephropathy) Global Clinical Trials Review, H##, 2020 List of Tables List of Figures Report Guidance GlobalData Clinical Trials Report Coverage Clinical Trials by Region Clinical Trials and Average Enrollment by Country Top Five Countries Contributing to Clinical Tri

  • Chronic Disease
  • Clinical Trial
  • Renal Disease
  • Therapy
  • World
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics Development

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview End-stage kidney disease is the complete or almost complete failure of the kidneys to work.

  • Renal Disease
  • Therapy
  • United States
  • World
  • CTI BioPharma Corp.

Polycystic Kidney Disease - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2020 ##.

  • Chronic Disease
  • Renal Disease
  • United States
  • World
  • Polycystic Kidney Disease - Overview
  • Polycystic Kidney Disease - Dormant Projects

About RGLS## ADPKD is a relatively common inherited genetic kidney disease occurring in between ##:## and ##:## patients and the ##th leading cause of end stage renal disease in the United States.

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative
  • Polycystic Kidney Disease - Overview
  • Polycystic Kidney Disease - Discontinued Products

The poster presentations will include one-year data from the Phase II portion of CARDINAL, a Phase II/ III trial of bardoxolone in patients with Alport syndrome, and ##-week data from the autosomal dominant polycystic kidney disease, IgA nephropathy, and type

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative
  • Clinical Trial profile. 327 Trial Title
  • Clinical Trial profile. 285 Trial Title

CLINICAL TRIALS BY END POINT STATUS ANEMIA IN CHRONIC KIDNEY DISEASE (RENAL ANEMIA) THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* ANEMIA IN CHRONIC KIDNEY DISEASE (RENAL ANEMIA) THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* AN

  • Pharmaceutical
  • Renal Disease
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • DRUG FOR KIDNEY DISEASES - DRUG PROFILE
  • DRUG FOR KIDNEY DISEASES - DRUG PROFILE

Chronic Kidney Disease (Chronic Renal Failure) - Overview Chronic Kidney Disease (Chronic Renal Failure) - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE), H## 2020 PIPELINE OVERVIEW

  • Chronic Disease
  • Genitourinary System Disease
  • Renal Disease
  • United States
  • Product Initiative
  • DRUG FOR KIDNEY DISEASES - DRUG PROFILE
  • CELL THERAPY FOR KIDNEY DISEASE - DRUG PROFILE

Chronic Kidney Disease (Chronic Renal Failure) - Overview Chronic Kidney Disease (Chronic Renal Failure) - Therapeutics Development NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE), H## 2019 PIPELINE OVERVIEW

  • Chronic Disease
  • Genitourinary System Disease
  • Renal Disease
  • United States
  • Product Initiative
  • Stage of Development
  • Stage of Development

PRODUCTS IN PHASE II/ III AND I/ II ARE REFLECTED UNDER PHASE III AND PHASE II, RESPECTIVELY Phase III ## ## Phase II ## ## Phase I ## ## IND/ CTA Filed ## ## Preclinical ## ## Discovery ## ## Total ## ## Stage of Development Company Universities/ Institutes Source: GBI Research Angio

  • Molecular Diagnostics
  • Pathology
  • Pharmaceutical
  • Renal Disease
  • Therapy

Kidney Disease Global Clinical Trials Review, H##, 2017 Table of Contents ## List of Tables ## List of Figures ## Report Guidance ## GlobalData Clinical Trials Report Coverage ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributi

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • World
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS, CENTRAL AND SOUTH AMERICA, TOP
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS, MIDDLE EAST AND AFRICA, TOP FIVE

END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CLINICAL TRIALS BY PHASE IN E## COUNTRIES END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUT

  • Chronic Disease
  • Clinical Trial
  • Renal Disease
  • Therapy
  • World

The report focuses on drugs and therapies being evaluated for End-Stage Kidney Disease (end-stage renal disease or ESRD) treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Chronic Disease
  • Clinical Trial
  • Pathology
  • Renal Disease

Insights into Polycystic Kidney Disease Pipeline ##.

  • Chronic Disease
  • Renal Disease
  • World

Polycystic Kidney Disease Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Polycystic Kidney Disease Trials ## Clinical Trials Trends to 2022 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease

2019 Polycystic Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease

2019 End Stage Renal Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease

2019 End Stage Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease

Insights into End Stage Renal Disease (ESRD) Pipeline ##.

  • Chronic Disease
  • Renal Disease
  • World
  • CHRONIC KIDNEY DISEASE (CKD)
  • UPDATES

GENE THERAPY GENE THERAPY COULD BE ONE OF THE PERFECT TREATMENT FOR RENAL DISEASES BECAUSE OF LIMITED THERAPEUTIC MOLECULE AND MINIMIZED SYSTEMIC EFFECT IN THE KIDNEY.

  • Renal Disease
  • Angion Biomedica Corp.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

2019 Polycystic Kidney Disease Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • APAC

2019 End-Stage Renal Disease(ESRD) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • APAC

2019 End-Stage Kidney Disease Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • APAC
  • 1.1 CHRONIC KIDNEY DISEASE (CKD)
  • 1.2 END STAGE RENAL DISEASE (ESRD)

There are five stages; kidney function is normal at Stage ## and reduced at Stage ##.

  • Renal Disease
  • World
  • Forecast
  • Market Size
  • Baxter International Inc.
  • Renal Diseases, Global, Overall
  • Renal Diseases, Global, Percentage

Targeting the MCP-##/ CCR## System in Diabetic Kidney Disease.

  • Chronic Disease
  • Pathology
  • Renal Disease
  • Deals & Alliance
  • Galectin Therapeutics Inc.